Enforcement Report - Week of December 15, 2021
A maker of over-the-counter products that include medicines for infants and children has been told by the FDA that it must completely remake its water system because it failed to prevent high levels of bacteria in its products.
RIJ Pharmaceutical LLC Receives FDA Warning Letter
The diversion of pharmaceutical preparations containing narcotics and precursors like ephedrine and pseudoephedrine to illicit channels in India remains a major challenge for law enforcement agencies, a global body's report has said.
Mylan NV’s shareholders voted in favor of moving forward with a $33 billion hostile bid for over-the-counter drugmaker Perrigo Co., putting the fate of the deal in Perrigo investors’ hands.
Sanofi`s ALLEGRA-D (Fexofenadine Hcl; Pseudoephedrine Hcl) Approved in US For Allergic Rhinitis.
Actavis Generic Guaifenesin/Pseudoephedrine combination Approved in US For Cough